Authorea (Authorea),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 27, 2023
Rose-derived
stem
cell
exosomes
for
recalcitrant
to
treatment
of
seborrheic
dermatitis
with
3
months
follow-up:
A
case
report
Key
Clinical
Message:Rose-derived
can
be
a
promising
therapeutic
option
severe
dermatitis.Their
anti-inflammatory
effects
and
epidermal
barrier
restoration
potential
suggest
valuable
adjunctive
treatment.However,
further
comprehensive
randomized
clinical
trials
are
recommended
validation.
Journal of Extracellular Vesicles,
Journal Year:
2024,
Volume and Issue:
13(5)
Published: May 1, 2024
Abstract
Extracellular
vesicles
(EVs)
are
released
by
all
cells
and
contribute
to
cell‐to‐cell
communication.
The
capacity
of
EVs
target
specific
efficiently
deliver
a
composite
profile
functional
molecules
have
led
researchers
around
the
world
hypothesize
their
potential
as
therapeutics.
While
studies
EV
treatment
in
animal
models
numerous,
actual
clinical
benefit
humans
has
more
slowly
started
be
tested.
In
this
scoping
review,
we
searched
PubMed
other
databases
up
31
December
2023
and,
starting
from
13,567
records,
selected
40
pertinent
published
testing
therapeutics
humans.
analysis
those
shows
that
they
small
pilot
trials
with
large
heterogeneity
terms
administration
route
disease.
Moreover,
absence
placebo
control
most
studies,
predominant
local
application
formulations
inconsistent
dose
metric
still
impede
comparison
across
firm
conclusions
about
safety
efficacy.
On
hand,
recording
some
promising
outcomes
strongly
calls
out
for
well‐designed
larger
test
an
alternative
approach
treat
human
diseases
no
or
few
therapeutic
options.
Journal of Cosmetic Dermatology,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 1, 2025
ABSTRACT
Background
Exosomes
are
extracellular
vesicles,
composed
of
a
phospholipid
bilayer,
that
primarily
derived
from
stem
cells.
The
contents
exosomes
can
be
incorporated
into
the
tissue
in
which
they
introduced,
presents
unique
therapeutic
option.
Aims
have
been
investigated
as
treatment
for
number
medical
ailments,
but
literature
supporting
these
indications
is
inconclusive.
In
addition,
much
study
on
and
their
uses
has
recently
completed.
Thus,
this
review
summarizes
efficacy
implications
different
dermatologic
conditions.
Methods
A
surrounding
use
multiple
dermatological
conditions
was
conducted.
Additionally,
we
present
numerous
practical
cases
patients
had
treated
with
exosomes.
Results
Overall,
success
treating
demonstrated
varying
literature,
preliminary
evidence
generally
positive.
patient
also
showed
satisfactory
clinical
outcomes
further
studies
will
necessary
to
fully
characterize
ideal
modalities
application,
including
formulation,
mode
distribution,
frequency
treatment.
Conclusions
may
serve
an
effective
option
wound
healing,
reconstruction
skin
flaps,
radiation
dermatitis,
acne
vulgaris,
psoriasis,
atopic
allergic
contact
lichen
simplex
chronicus,
vulvar
sclerosis,
systemic
lupus
erythematosus,
vitiligo
although
additional
needed
confirm
safety.
International Journal of Nanomedicine,
Journal Year:
2025,
Volume and Issue:
Volume 20, P. 2673 - 2693
Published: March 1, 2025
Atopic
dermatitis
(AD)
is
a
global
concern
marked
by
inflammation,
skin
barrier
dysfunction,
and
immune
dysregulation.
Current
treatments
primarily
address
symptoms
without
offering
cure,
underscoring
the
need
for
innovative
therapeutic
approaches.
Mesenchymal
stromal
cell-derived
extracellular
vesicles
(MSC-EVs)
have
attracted
attention
their
potential
in
immunomodulation
tissue
repair,
similar
to
parent
cells.
This
review
provides
comprehensive
analysis
of
current
landscape
MSC-EV
research
AD
management.
We
identified
12
studies
that
met
our
predefined
inclusion
criteria.
thoroughly
reviewed
both
human
animal
studies,
analyzing
aspects
such
as
source,
isolation,
characterization
MSC-EVs,
well
disease
models,
dosage
strategies,
efficacy,
mechanisms,
adverse
effects.
While
this
highlights
promising
therapy
AD,
it
also
emphasizes
significant
challenges,
including
heterogeneity
insufficient
reporting.
Given
area
still
its
early
stages,
addressing
these
uncertainties
will
require
collaborative
efforts
among
researchers,
regulatory
bodies,
international
societies
advance
field
improve
patient
outcomes.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 24, 2025
Studies
examining
the
therapeutic
potential
of
Mesenchymal
stem
cells-derived
extracellular
vesicles
(MSC-EVs)
in
wound
healing
and
skin
regeneration
have
progressed
rapidly.
Prior
to
considering
clinical
translation,
a
systematic
comprehensive
understanding
these
experimental
details
overall
impact
MSC-EVs
on
is
necessary.
83
studies
were
identified
Web
Science,
Embase,
PubMed
that
satisfied
set
prespecified
inclusion
criteria.
A
random
effects
meta-analysis
was
conducted
for
closure
rate,
scar
width,
blood
vessel
density
collagen
deposition.
Our
findings
demonstrate
clear
be
developed
as
therapy
both
diabetic
non-diabetic
animal
models.
Moreover,
subgroup
analyses
demonstrated
apoptotic
small
(ApoSEVs)
showed
better
efficacy
than
bodies
(ApoBDs)
(sEVs)
outcome
deposition,
while
sEVs
displayed
ApoEVs
revascularization.
Among
frequently
used
routes
administration,
subcutaneous
injection
greater
improvement
closure,
deposition
revascularization
compared
dressing/covering.
easier-access
source
MSCs,
ADSCs
best
effect
rate
compared,
BMMSCs
Additionally,
high
heterogeneity
observed
collection
conditions,
separation
methods,
storage
modifications,
treatment
dose,
administration
route,
frequency
underscores
urgent
need
standardization
areas,
prior
translation.
PROSPERO
CRD42024499172.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(5), P. e0322497 - e0322497
Published: May 6, 2025
Conditioned
medium
(CM)
derived
from
human
mesenchymal
stem
cells
(MSCs)
has
shown
potential
as
a
therapeutic
agent.
However,
the
safety
of
its
administration
in
remains
largely
unexplored.
This
study
evaluated
multiple
systemic
administrations
MSC-CM,
specifically
adipose-derived
and
umbilical
cord-derived
55
patients
with
various
chronic
diseases.
Symptom
assessments
blood
tests
were
conducted
before
after
to
monitor
adverse
events
measure
inflammatory
marker
C-reactive
protein
(CRP),
respectively.
The
results
demonstrated
no
serious
attributed
MSC-CM
administration.
Although
minor
observed,
their
causal
relationship
remained
unclear.
Additionally,
slightly
reduced
CRP
levels,
regardless
route
(intraarterial,
intravenous,
or
inhalation).
significant
reduction
levels
was
observed
elevated
(CRP
>
0.3)
following
These
findings
suggest
that
repeated
is
likely
safe
may
have
anti-inflammatory
effects.
Cosmetics,
Journal Year:
2024,
Volume and Issue:
11(5), P. 154 - 154
Published: Sept. 7, 2024
Recent
advancements
in
aesthetic
medicine
offer
innovative
cosmetic
solutions
to
enhance
patient
skin
quality
and
appearance.
Advanced
treatment
options
enable
practitioners
effectively
address
aging
signs,
pigmentation
imbalance,
loss
of
elasticity
ambulatory
home-based
care
regimens.
Exosomes
(nanoscale
cell-derived
vesicles)
transport
a
variety
biomolecules
are
pivotal
physiological
intercellular
communication.
Importantly,
exosomes
have
recently
emerged
as
key
endogenous
players
tissular
regeneration.
More
broadly
(from
an
active
ingredient
purity
standpoint),
exosomes,
stem
cell
secretomes,
culture-conditioned
media
been
clinically
proven
exert
multifaceted
beneficial
topical
effects
(anti-inflammatory,
antioxidant,
anti-aging,
rejuvenation).
Therefore,
human,
animal,
plant-derived
or
other
refined
sub-cellular
biological
fractions
gaining
substantial
interest
within
the
industries.
Notably,
such
approaches
thought
be
among
most
promising
novel
contenders
for
advanced,
biologically
inspired
prejuvenation
rejuvenation
care.
The
present
narrative
review
summarizes
latest
oriented
research
on
media,
highlighting
their
mechanisms
action
various
applications.
Furthermore,
it
explores
innovation
landscape
currently
commercially
available
products
global
market
discusses
potential
future
applications
ingredients
medical
industry.
Journal of Cosmetic Dermatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 3, 2024
Abstract
Introduction
Seborrheic
dermatitis
(SD)
poses
significant
treatment
challenges
due
to
its
chronic
nature
and
the
side
effects
associated
with
long‐term
use
of
conventional
therapies
like
topical
corticosteroids.
In
search
for
alternative
treatments,
exosomes,
particularly
those
derived
from
rose
stem
cells
(RSCEs),
offer
a
promising
avenue
their
potential
in
managing
skin
conditions.
Objective
This
case
report
examines
efficacy
moisturizer
containing
RSCEs
treating
patient
refractory
SD,
aiming
provide
an
pathway.
Materials
Methods
A
40‐year‐old
male
long‐standing
history
unresponsive
traditional
underwent
novel
regimen.
regimen
included
initial
application
2.5
mL
followed
by
maintenance
phase
involving
RSCE‐containing
moisturizer.
Clinical
outcomes
were
assessed
through
Patient's
Global
Assessment
(PGA)
Investigator's
(IGA)
scores,
along
evaluations
scaling
erythema.
Results
Remarkable
clinical
improvement
was
noted
as
early
1‐day
post‐treatment,
reductions
redness,
scaling,
itching.
The
experienced
sustained
relief
throughout
6‐month
follow‐up,
recurrence
sixth
month
that
less
severe
than
previous
flare‐ups.
demonstrated
not
only
symptom
management
but
also
extending
remission
periods.
Conclusion
SD
can
benefit
innovative
treatments
moisturizer,
shown
this
report.
While
observed
are
promising,
indicating
substantial
improvements
condition
management,
larger
controlled
studies
necessary
validate
therapeutic
exosome‐containing
moisturizers
fully.
underscores
need
treatment,
highlighting
role
exosomes
viable
option.
JAAD reviews.,
Journal Year:
2024,
Volume and Issue:
1, P. 135 - 174
Published: July 14, 2024
The
clinical
exploration
of
extracellular
vesicles
(EVs,
also
called
exosomes)
in
dermatology
has
recently
grown,
including
cosmeceuticals.
This
systematic
review
aimed
to
collate
existing
observations
on
EVs
for
either
therapeutic
intervention
or
as
a
diagnostic
prognostic
tool
and
critically
assess
the
degree
evidence
any
observed
feature.
Primary
studies
that
enrolled
patients
with
dermatologic
conditions
reported
role
were
included.
Screening
analysis,
data
extraction,
quality
assessment
performed
by
4
investigators.
GRADE-CERQual,
an
adapted
approach
assessing
certainty
qualitative
sytematic
reviews,
was
utilized
determine
confidence
data.
Outcomes
included
effectiveness
EVs'
formulations,
their
safety,
potential.
Fifty-two
reporting
from
3066
Methodologic
inconsistencies,
poor
reporting,
low
numbers
reduced
certainty.
potential
utilization
studied
but
have
not
been
validated.
are
being
introduced
into
practices
globally
Observational
implied
some
efficacy,
regulatory
perspective,
our
knowledge,
no
EV-based
therapeutics
approved
dermatology.
Future
trials
need
be
randomized,
double-blind,
placebo-controlled
support
approvals,
findings
supported
larger
cohorts.